Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 509.05 2.07
Bhel 226.95 2.83
Hindalco 163.25 1.68
Ong Corp 412.70 1.10
Tata Pow 87.30 2.05
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Claris Lifesciences Limited
Claris Lifesciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:533288NSE:NABloomberg:CLAR@INReuters:CLAI.BO
Market Lot: 1Face Value: 10ISIN Demat: INE562G01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
21-AUG-14 Claris Lifesciences, one of the largest sterile injectables pharmaceutical companies in India, has today announced that it has received MHRA approval for its newly commissioned plant (plant 2). This will help in enhancing capacities to grow in the regulated markets, especially the European Union. The company`s specialty injectables business saw a growth of 30% in the last quarter. 09-JUL-14 Claris Lifesciences, one of the largest ste...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Claris Lifesciences jumps on MHRA nod for new plant  -IRIS 21-Aug-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(6)31-Dec-2013 (12)31-Dec-2012(12)
Net sales 2625.146287.947140.72
Other Income317.90404.95147.73
Total Income2943.046692.897288.45
Cost of goods sold2290.624804.654927.97
OPBDIT652.421888.242360.48
PAT301.72812.19744.17
Gross Block---
Equity capital545.68638.18638.18
EPS (Rs.)-12.73-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-11.16 - 18.22-
Debt / Equity (x)---
Operating margin (% of OI)22.228.232.4
Net margin (% of OI)10.312.110.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Claris Corporate Headquarters
Near Parimal Railway Crossing
Ellisbridge
Ahmedabad
Gujarat-380 006
PHONE
(079) 2656 3331/ 6630 9330
FAX
(079) 2656 5879/ 2640 8053
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | E-mail | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer